Immunity for Health 2017


On October 20th 2017 Flanders Vaccine is happy to host its second edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.

The theme of this year’s edition is “Learning the rules of the immune system: a translational approach“. We are honoured to welcome some internationally renowned experts in the field and are looking forward to be inspired by their talks!

Venue: Elzenveld, Lange Gasthuisstraat 45, 2000 Antwerpen (Attention! Leien closed in both directions: click here to plan your route to Antwerp)


Preliminary programme – October 20th, 2017:

OPENING SESSION Orchestrating immune responses in humans and animals to prevent and treat disease – many challenges, one health
Chair: Sven Arnouts, Chairman of the Board, Flanders Vaccine

08:45  WELCOME

09:00  OPENING KEYNOTE 1 – topic “One Health”
Ab Osterhaus, Director Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Germany

09:30  KEYNOTE 2 – topic Systems Biology of Vaccination”
Helder Nakaya, Professor University of Sao Paulo, Brazil and Emory University, USA

10:00  KEYNOTE 3: Using dendritic cells as immune orchestrators for therapeutic vaccination of cancer patients
Evelien Smits, Professor Tumor Immunology, University of Antwerp & Antwerp University Hospital


MORNING SESSION II – Enhancing the value of clinical trials starts with sharing data & experiences – let’s do so
Chair: Pierre Van Damme, Flanders Vaccine track lead Clinical trials

10:50  topic – “Clinical trials in Belgium”
Greet Musch, Director General PRE Authorisation, FAMHP

11:11  topic – “Vaccine trials in children and infants – lessons learnt from Finland”
Timo Vesikari, Director Vaccine Research Center, University of Tampere, Finland

11:40  Pitch your clinical research – vaccines & immunotherapeutics

12:20  LUNCH

AFTERNOON SESSION I: The power of the porcine immune system – learning from different worlds
Chair: Hugo Van Heuverswyn, Flanders Vaccine track lead R&D

13:50 topic “Therapeutic vaccines”
Gregers Jungersen, Professor Immunology and Vaccinology, National Veterinary Institute Copenhagen, Denmark

14:20  topic “Porcine and murine versus human immunome”
Harry Dawson, Research Scientist USDA/ARS, Beltsville Human Nutrition Research Center, USA

14:50  R&D track launches call for action + Pitch your collaboration incentive
Hugo van Heuverswyn, CEO BioMARIC


CLOSING SESSION: Fostering innovation & developing new preventive and therapeutic tools takes joint efforts
Chair: Henk Joos, Flanders Vaccine track Regional & International visibility

15:40  topic Human Vaccines Project: accelerate development of vaccines and immunotherapies by decoding the immune system
Johan Van Hoof,  Global Therapeutic Area Head for Infectious Diseases and Vaccines & Managing Director Crucell, Janssen Pharmaceutica

16:00  topic Vaccine landscape in Belgium
Stéphanie Mali, Coordinator Center of Excellence for Vaccines, FAMHP

16:20 CLOSING KEYNOTE IV: Gold sponsor (Do you want to become our gold sponsor? Please contact us!)

16:50 Closing remarks
Sven Arnouts, Chairman of the Board, Flanders Vaccine